Ceramic-based biomaterials: Combining regeneration with anti-senescence

Apr 5, 2026Biomaterials

Ceramic Materials That Support Tissue Repair and Reduce Cell Aging

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗

Abstract

Silicate bioceramics, specifically hardystonite (ZnCS), may delay cellular aging and promote bone formation.

Hardystonite exhibits biphasic biological functions by both delaying cellular senescence and enhancing bone formation.
In vitro studies show that ZnCS delays senescence in bone marrow mesenchymal stem cells and boosts their ability to develop into bone cells.
In vivo, ZnCS 3D scaffolds improve the aging bone environment and promote regeneration in osteoporotic models.
Oral administration of ZnCS particles demonstrates significant effects in reducing osteoporosis.
Zn and SiO ions released from ZnCS work together to influence specific cellular signaling pathways, reducing aging-related changes and supporting bone gene activity.
ZnCS outperforms traditional anti-senescence drugs in promoting both anti-aging and bone growth effects.

AI simplified

The global aging crisis presents significant challenges in treating age-related skeletal disorders, characterized by impaired bone regeneration due to senescent microenvironment dysfunction. While anti-senescence drugs have shown promising therapeutic potential, their clinical use is hindered by severe side effects and limited regenerative efficacy. Biomaterials-based anti-senescence strategies offer a promising alternative. This study is the first to demonstrate that silicate bioceramics possess not only osteogenic properties but also intrinsic anti-senescence capabilities, laying the foundation for the concept of "Silicate Anti-Senescence (SAS)". Using hardystonite (CaZnSiO, ZnCS), one of the classic silicate-bioceramics, we reveal its biphasic biological function-delaying cellular senescence and promoting bone formation-through various formulations, including porous scaffolds, ionic extracts, and particle suspensions. In vitro, ZnCS effectively delays senescence of bone marrow mesenchymal stem cells (BMSCs) and enhances osteogenic differentiation. In vivo, ZnCS 3D scaffolds remodel the senescent microenvironment and accelerate osteoporotic bone regeneration, while oral administration of ZnCS particles exhibits significant anti-osteoporotic effects. Mechanistically, Znand SiOions released from ZnCS exert synergistic effects that converge on the PI3K-AKT-SIRT1 signaling axis, thereby attenuating senescence-associated programs and reinforcing osteogenic gene networks. Notably, compared to classic anti-senescence drugs (dasatinib and quercetin), ZnCS shows superior performance compared to the control groups in both anti-senescence and osteogenesis. The study provides new insights into developing anti-senescence strategies for age-related skeletal diseases with silicate-based bioceramics. 2 2 7 3 2+ 2-

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Ceramic-based biomaterials: Combining regeneration with anti-senescence

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief